The federal government’s Operation Warp Speed has made its biggest financing award yet, promising $1.6 billion to a Maryland biotech to help advance its investigational COVID-19 vaccine and ready millions of doses in preparation for its possible success.

Gaithersburg, MD-based Novavax, which has never before brought a product to market, announced the federal award Tuesday. The money is the latest allocation made out of the funds allocated to Operation Warp Speed (OWS), a multiagency effort to assist companies in readying effective COVID-19 vaccines.

Previously Novavax secured commitments from the Coalition for Epidemic Preparedness Innovations and the Department of Defense of up… Read more »